Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.

Abstract

BACKGROUND We compared the clinical effectiveness of oseltamivir and zanamivir in children with influenza A (H1N1) virus, influenza A (H3N2) virus, and influenza B virus infections. METHODS Total febrile period and the duration of fever after the start of treatment were compared between an oseltamivir-treated group (mean age, 8.9 years; range, 4.0-15.9 years) and a zanamivir-treated group (mean age, 10.0 years; range, 4.0-15.7 years) in the pediatric outpatient clinics of our hospitals. Oseltamivir was used to treat 91 children with influenza A (H3N2) infection and 24 children with influenza A (H1N1) infection. Zanamivir was used to treat 35 children with influenza A (H3N2) infection and 12 children with influenza A (H1N1) infection. Oseltamivir was also used to treat 128 children with influenza B virus infection, and zanamivir was used to treat 59 with influenza B virus infection. RESULTS There was no statistically significant difference in total febrile period or duration of fever after the start of treatment between the oseltamivir-treated group and the zanamivir-treated group of children with influenza A (H3N2) infection (mean duration of febrile period, 2.40 days vs. 2.39 days; mean duration of fever after the start of treatment, 1.35 days vs. 1.40 days), influenza A (H1N1) (mean duration of febrile period, 2.60 days vs. 2.46 days; mean duration of fever after the start of treatment, 1.79 days vs, 1.54 days), or influenza B (mean duration of febrile period, 2.95 days vs. 2.84 days; mean duration of fever after the start of treatment, 1.86 days vs. 1.67 days). Oseltamivir was more effective against influenza A (H3N2) than against influenza A (H1N1) or influenza B. CONCLUSIONS Oseltamivir and zanamivir were equally effective in reducing the febrile period of children with influenza A (H1N1), influenza A (H3N2), and influenza B virus infection.

DOI: 10.1086/589748

3 Figures and Tables

Showing 1-10 of 12 references

Infectious Disease Surveillance Center (IDSC). 2006/07 Influenza season , Japan. Infect Agents Surveillance Rep

  • 2007

New concerns about oseltamivir

  • 2007

Treatment of influenza patients in their teens, side effects of oseltamivir, abnormal behavior and fall from buildings

  • N Sugaya
  • 2007

Infectious Disease Surveillance Center (IDSC) Influenza 2005/06 season , Japan. Infect Agents Surveillance Rep

  • 2006
Showing 1-10 of 12 extracted citations

Statistics

0102030200920102011201220132014201520162017
Citations per Year

72 Citations

Semantic Scholar estimates that this publication has received between 14 and 230 citations based on the available data.

See our FAQ for additional information.